These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28617855)

  • 1. Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.
    Alvaro-Meca A; Berenguer J; Díaz A; Micheloud D; Aldámiz-Echevarría T; Fanciulli C; Resino S
    PLoS One; 2017; 12(6):e0179493. PubMed ID: 28617855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological trends of deep venous thrombosis in HIV-infected subjects (1997-2013): A nationwide population-based study in Spain.
    Alvaro-Meca A; Ryan P; Martínez-Larrull E; Micheloud D; Berenguer J; Resino S
    Eur J Intern Med; 2018 Feb; 48():69-74. PubMed ID: 29102088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Epidemiology of COPD in HIV-Infected Patients in Spain (1997-2012).
    de Miguel-Díez J; López-de-Andrés A; Jiménez-García R; Puente-Maestu L; Jiménez-Trujillo I; Hernández-Barrera V; Resino S; Álvaro-Meca A
    PLoS One; 2016; 11(11):e0166421. PubMed ID: 27846297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based study.
    Alvaro-Meca A; Ryan P; Micheloud D; De Miguel A; Berenguer J; Resino S
    Sci Rep; 2018 Aug; 8(1):12137. PubMed ID: 30108235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
    Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
    Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
    Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
    Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.
    Meijide H; Pértega S; Rodríguez-Osorio I; Castro-Iglesias Á; Baliñas J; Rodríguez-Martínez G; Mena Á; Poveda E
    AIDS; 2017 May; 31(8):1099-1107. PubMed ID: 28441174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD
    Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals.
    Rohrbach J; Stickel F; Schmid P; Thormann W; Kovari H; Scherrer A; Günthard HF; Vuichard D; Cavassini M; Ambrosioni J; Bernasconi E; Furrer H; Rauch A;
    Antivir Ther; 2014; 19(2):149-59. PubMed ID: 24036684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
    Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ;
    Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.
    Nicolás D; Esteve A; Cuadros A; Campbell CNJ; Tural C; Podzamczer D; Murillas J; Homar F; Segura F; Force L; Vilaró J; Masabeu À; Garcia I; Mercadal J; Montoliu A; Ferrer E; Riera M; Cifuentes C; Ambrosioni J; Navarro G; Manzardo C; Clotet B; Gatell JM; Casabona J; Miró JM; ; Murillas J; Manzardo C; Masabeu A; Mercadal J; Cifuentes C; Dalmau D; Domingo P; Falcó V; Curran A; Agustí C; Montoliu A; Pérez I; Curto J; Gargoulas F; Gómez A; Rubia JC; Zamora L; Blanco JL; Garcia-Alcaide F; Martínez E; Mallolas J; Llibre JM; Sirera G; Romeu J; Jou A; Negredo E; Saumoy M; Imaz A; Bolao F; Cabellos C; Peña C; DiYacovo S; Van Den Eynde E; Sala M; Cervantes M; Amengual MJ; Navarro M; Segura V; Barrufet P; Molina J; Alvaro M; Payeras T; Gracia Mateo M; Fernández J
    Clin Infect Dis; 2016 Jun; 62(12):1578-1585. PubMed ID: 27126346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.
    Chromy D; Mandorfer M; Bucsics T; Schwabl P; Bauer D; Scheiner B; Schmidbauer C; Lang GF; Szekeres T; Ferenci P; Trauner M; Reiberger T
    AIDS Patient Care STDS; 2019 May; 33(5):197-206. PubMed ID: 31067123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).
    Vázquez-Morón S; Berenguer J; González-García J; Jiménez-Sousa MÁ; Canorea I; Guardiola JM; Crespo M; Quereda C; Sanz J; Carrero A; Hontañón V; Avellón A; Resino S
    Sci Rep; 2019 Feb; 9(1):1143. PubMed ID: 30718554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
    García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV coinfection possibly promotes left ventricular dysfunction development: analysis of brain natriuretic peptide serum levels in HCV/HIV-coinfected and HIV-monoinfected patients.
    Dabrowska MM; Mikula T; Wiercinska-Drapalo A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1308-12. PubMed ID: 22825646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.